About the Journal
Focus and Scope
As the official journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol (KBS), the overall goal of the International Journal of Alcohol and Drug Research (IJADR) is to further the main aims of the Kettil Bruun Society which are to promote social and epidemiological research on alcohol and foster a comparative understanding of alcohol use and alcohol problems in a spirit of international cooperation.
In furtherance of this overall goal, the aims of the International Journal of Alcohol and Drug Research are to:
- publish high quality, peer reviewed articles addressing substance use and substance-related problems, as well as addictive behaviours generally, from an international perspective,
- increase international knowledge and understanding about substance use and substance-related problems by providing mentoring and other assistance to research colleagues in countries where there are fewer resources and less infrastructure and traditional support of research on alcohol and drugs,
- promote involvement of early career researchers and researchers from less resourced countries in all aspects of the journal operations, and
- provide an open access online journal accessible to the research community, educators, policy makers and others interested in the area of substance use and substance-related issues.
The International Journal of Alcohol and Drug Research publishes both quantitative and qualitative research as well as scholarly commentaries, case studies, book reviews and other types of reports relating to all aspects of alcohol and drug use provided the focus is on enhancing understanding from an international perspective. This includes research reports from countries where there is little current knowledge about substance use as well as cross-national comparisons and other studies that have global implications.
Materials published by IJADR represent the opinions of the authors and do not reflect the opinions of the journal or the Kettil Bruun Society for Social and Epidemiological Research on Alcohol unless specifically endorsed by the journal or the society.
IJADR is currently addressing requirements of various indexing sites such as DOAJ, EBSCO, PsychINFO, PubMed, SSCI, and ProQuest.
Peer Review Process
The Editorial Team manages submissions to the International Journal of Alcohol and Drug Research by assessing whether the manuscript addresses the aims of the journal and is of sufficient scientific quality to be considered for publication. That is, the study must meet an acceptable level of scientific rigor and make a significant contribution to knowledge to be considered for peer review. Each manuscript is sent to two experts in the topic area for peer review. This review process is managed by one of the Editorial Team directly or through one of the Consulting Editors or Special Issue Editors.
Submitted manuscripts are evaluated using the following guidelines:
- originality, contribution to the field of substance use and substance-related issues,
- soundness of methodology,analyses and interpretation/discussion of analyses,
- clarity of presentation, and
- ability to communicate to readers (grammar, language).
The Editorial Team may suggest advice from or collaboration with a Consulting Editor or a mentor from the International Society of Addiction Journal Editors (ISAJE) mentoring program to authors of manuscripts that have the potential to meet the aims of the journal but require extensive revisions. The Editorial Team is committed to providing mentorship to authors who are early career researchers and/or researchers from less resourced countries.
Open Access Policy
The International Journal of Alcohol and Drug Research provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Editorial Ethics Policy
The Kettil Bruun Society (KBS), the Centre for Addiction and Mental Health (CAMH), The Ohio State University (OSU) and the National Institute on Drug Abuse (NIDA) respect and endorse the independence of the International Journal of Alcohol and Drug Research Editors and exerts no authority over them.
The International Journal of Alcohol and Drug Research endorses and adheres to the ethical publishing guidelines for addiction journals outlined in the Farmington Consensus (Addiction (1997) 92(12), 1617-1618). http://www.parint.org/isajewebsite/farmcon.pdf
The International Journal of Alcohol and Drug Research is committed to a high standard of editorial ethics. Members of the Editorial Team of the journal have provided the following statements relating to their own research interests, funding sources, commercial relationships, or other interests that may be, or seem to be, potential sources of conflict of interests or to influence their editorial independence and/or judgments. The International Journal of Alcohol and Drug Research editors and reviewers may be excluded from reviewing papers if they appear as an author on the paper, are from the same institution/organization, have conflicts related to financial interests, or have a personal conflict that have or appear to have an influence on their ability to be an impartial reviewer.
The International Journal of Drug and Alcohol Research charges $750 US per manuscript of up to 3,000 words (excluding references, tables, and figures). There will be an additional cost of $150 per 500 words over the word limit. These fees are necessary in order to keep the journal operational for the long-term and to provide open access. Fees waivers will be considered for authors from low-income countries or authors with documented needs. To request a publication fee waiver, please contact the editor in advance of submission providing justification.
The International Journal of Alcohol and Drug Research is sponsored by the Kettil Bruun Society for Social and Epidemiological Research on Alcohol (KBS)
The International Journal of Alcohol and Drug Research was created in 2011 through collaboration between the Kettil Bruun Society (KBS), the Centre for Addiction and Mental Health (CAMH) and the National Institute on Drug Abuse (NIDA). The first issue was published in June 2012.